Product Details for: Elrexfio

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
76MG/1.9ML (40MG/ML)
Single-Dose Vial
351(a)
Elrexfio
Rx
002
Injection
Subcutaneous
44MG/1.1ML (40MG/ML)
Single-Dose Vial
351(a)
Elrexfio
Rx
Proper Name
elranatamab-bcmm
BLA Number
761345
Applicant
Pfizer Inc.
Original Approval Date
August 14, 2023
Date of First Licensure
RETURN TO SEARCH RESULTS